Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CK2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CK2 (Casein Kinase 2) is a constitutively active serine/threonine protein kinase that phosphorylates over 300 substrates involved in transcription, translation, cell cycle, and cell survival. It is implicated in Alzheimer's disease tau pathology and cancer.
No AI portrait yet
| Gene Symbol | CK2 |
| Aliases | Casein Kinase 2 |
| Function | CK2 exists as a tetrameric holoenzyme composed of two catalytic subunits (α or α') and two regulatory β subunits. The regulatory β subunit enhances substrate specificity, modulates activity, and ta... |
| Molecular Weight | 44 kDa |
| Pathways | Notch Signaling, blood-brain barrier |
| GeneCards | CK2 |
| Human Protein Atlas | CK2 |
| Associated Diseases | ALS, Alzheimer, Huntington's disease |
| Interactions | AQP4, ATP, BRAF, MAPK, MYH9, NPM1 |
| KG Connections | 46 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
N0["CK2"]
N1["Notch Signaling"]
N0 -->|"regulates"| N1
N2["MYH9"]
N0 -->|"phosphorylates"| N2
N3["E(SPL)M8"]
N0 -->|"phosphorylates"| N3
N4["Neurogenesis"]
N4 -->|"involved in"| N0
N5["KIF5"]
N0 -->|"phosphorylates"| N5
N6["PP2A"]
N0 -->|"interacts with"| N6
N7["MAPK"]
N7 -->|"regulates"| N0
N8["BRAF"]
N8 -->|"activates"| N0
N9["CDK1"]
N9 -->|"co discussed"| N0
N7 -->|"activates"| N0
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
class N1 pathway
class N2 protein
class N3 protein
class N5 protein
class N7 pathway
class N8 gene
class N9 gene| Target | Relation | Type | Str |
|---|---|---|---|
| MYH9 | phosphorylates | protein | 0.87 |
| PP2A | associated_with | gene | 0.60 |
| ALS | associated_with | disease | 0.60 |
| Alzheimer | associated_with | disease | 0.60 |
| IRS1 | regulates | gene | 0.60 |
| KIAA1549 | regulates | gene | 0.60 |
| MAPK | regulates | gene | 0.60 |
| DRP1 | regulates | gene | 0.60 |
| FUNDC1 | regulates | gene | 0.60 |
| OPA1 | regulates | gene | 0.60 |
| ULK1 | regulates | gene | 0.60 |
| Alzheimer's disease | regulates | disease | 0.60 |
| mitochondrial function | participates_in | pathway | 0.60 |
| GSK3 | implicated_in | gene | 0.60 |
| MAPK | implicated_in | gene | 0.60 |
| Huntington's disease | implicated_in | disease | 0.60 |
| Wnt signaling | participates_in | pathway | 0.60 |
| IKK | regulates | gene | 0.60 |
| MAPK14 | regulates | gene | 0.60 |
| PP2A | regulates | gene | 0.60 |
| PP2B | regulates | gene | 0.60 |
| PERK | targets | gene | 0.60 |
| HDAC3 | associated_with | gene | 0.60 |
| PERK | activates | gene | 0.60 |
| glymphatic clearance | participates_in | pathway | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| Notch signaling | participates_in | pathway | 0.60 |
| PP2A | inhibits | gene | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| CSNK2 | regulates | gene | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| stroke | activates | disease | 0.60 |
| PKC | activates | gene | 0.55 |
| blood-brain barrier | participates_in | pathway | 0.55 |
| NPM1 | activates | gene | 0.55 |
| PERK | co_expressed_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| H1: CK2 Hyperphosphorylation Locks G3BP1 in Hyper-condensed | 0.637 | neurodegeneration | How do pathological stress granules tran |
| Casein Kinase 2 (CK2)-Mediated Hyperphosphorylation of G3BP1 | 0.440 | neurodegeneration | How do pathological stress granules in n |
| CK2-mediated HSP90α phosphorylation switches client discrimi | 0.363 | protein biochemistry | Do chaperones selectively recognize path |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CK2 in their description or question text
No additional research found